PUBLICATIONs

THE LATEST PUBLICATIONS

Open to Debate: Is the FDA’s Caution Hazardous to your Health?

World Congress: AI and Digital Twins to Drive the Next Generation Drug Discovery and Development

Servier Doubles Up on Digital Twin Alliance with Aitia

Companies to Focus on Therapeutic Targets Showing Cause and Effect

UCB Enters Drug Discovery Collaboration with Aitia

Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

Becoming Aitia: Why GNS Shifted from AI Provider to Drug Discoverer

New Biomarkers for Atherosclerosis Found Using Digital Twins

Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis development

The Milken Institute Future of Health Summit – “Is AI Just What the Doctor-or Patient-Ordered?” Panel Discussion